OncoAlly™ BRCA1/2 Analysis
Test Code – OA014
OncoAlly™ BRCA1/2 Analysis Analysis uses a whole genome sequencing platform to analyze the BRCA1 and BRCA2 genes for genetic variants associated with hereditary breast, ovarian, pancreatic and prostate cancer.
When to Order
Order this test when a patient has a personal or family history suggestive of hereditary breast or ovarian cancer predisposition or when germline variant analysis for hereditary breast or ovarian cancer predisposition is necessary to guide medical management.
- Sequence analysis of hereditary cancer-associated genes (single nucleotide variants, deletions, insertions, and characterized intronic variants)
- Copy number variant analysis of hereditary cancer-associated genes (duplications/deletions, mobile element insertions, and inversions)
The CPT codes provided are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
A report will be issued within 4 weeks from receipt of required samples.